 |
|
|
|
|
|
Introduction Human Veterinary Environmental Industrial Agricultural MSG
Introduction Medical Veterinary Environmental Industrial Agricultural
Introduction Susceptibility MIC Database Procedures Histopathology
Introduction Abbreviations Links CME Conference Highlights Bibliography Glossary Good Books Events Calendar
Introduction Our Mission Editorial Board Editorial Staff Supporters Contributors Legal Stuff Privacy Policy Kudos
Introduction Descriptions Synonyms Image Bank Lecture Bank Video Bank
This page updated:
1/27/2007 9:23:00 AM
DoctorFungus - All Rights Reserved
© 2007 Copyright
& Privacy Policy
Site built and designed for doctorfungus by Webillustrated
|
 |
 |
 |
|
You are here:
The Fungi
> Descriptions >
|
|
Candida famata var. famata
(Harrison) S.A. Meyer & Yarrow (Yarrow and Meyer 1978) (1985)
|
|
Debaryomyces hansenii (Zopf) Lodder & Kreger-van Rij var. hansenii (1985)
|
|
|
|
Candida famata var. flareri
(Ciferri & Redaelli) Nakase & Suzuki (1985b)
|
|
|
Debaryomyces hansenii var. fabryi (Ota) Nakase & M. Suzuki (1985b)
|
|
|
Colonies on Sabouraud dextrose agar at 25°C are grayish white to yellowish, dull to shiny, and smooth to wrinkled. The two varieties are distinguished by maximum growth temperature. Debaryomyces hansenii var. hansenii has a maximum growth temperature of 35°C while D. hansenii var. fabryi has a maximum growth temperature of 40°C and no growth on cycloheximide. This species is not distinguishable from several other species on Chromager Candida [1069].
On cornmeal following 72 hours incubation at 25°C, usually no pseudohyphae are evident. Rare strains have rudimentary to well-developed pseudohyphae.
Candida famata is an emerging pathogen that has been reported to have decreased susceptibility to amphotericin B [1775], [1776]. This species has been recovered from psoriasis, nails, and wounds [1270], the blood in a stem cell transplant patient [2347], and from the retina [382].
| AMB |
CAS |
5FC |
FLU |
ITRA |
VORI |
| 0.125 µg/ml=4 |
<0.03 µg/ml=5 |
<0.125 µg/ml=2 |
0.25 µg/ml=2 |
0.03 µg/ml=3 |
<0.015 µg/ml=3 |
| 0.25 µg/ml=3 |
0.25 µg/ml=2 |
2.0 µg/ml=1 |
0.5 µg/ml=4 |
0.06 µg/ml=2 |
0.03 µg/ml=3 |
| |
>16 µg/ml=1 |
|
1.0 µg/ml=4 |
0.25 µg/ml=2 |
|
| |
|
|
2.0 µg/ml=2 |
|
|
| |
|
|
4.0 µg/ml=3 |
|
|
| Drug/N |
AMB/7 |
CAS/8 |
5FC/3 |
FLU/15 |
ITRA/7 |
VORI/6 |
| MIC Range |
0.125-0.25 |
<0.03->16 |
<0.125-2.0 |
<0.125-4.0 |
0.03-0.25 |
<0.015-0.03 |
| MIC50 |
* |
* |
* |
1.0 |
* |
* |
| MIC90 |
* |
* |
* |
4.0 |
* |
* |
* Fungus Testing Laboratory unpublished data (NCCLS M27-A2)
PubMed
GenBank
|
|
|

References
382. Carrasco, L., M. Ramos, R. Galisteo, D. Pisa, M. Fresno, and M. E. Gonzalez. 2005. Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol. 43:635-40.
1069. Hospenthal, D. R., M. L. Beckius, K. L. Floyd, L. L. Horvath, and C. K. Murray. 2006. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 5:1.
1270. Kurtzman, C. P., and J. W. Fell (ed.). 2000. The Yeasts. A Taxonomic Study. Elsevier Scientific B.V., Amsterdam, The Netherlands.
1775. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol. 41:78-83.
1776. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2004. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis. 48:101-105.
2347. Wagner, D., A. Sander, H. Bertz, J. Finke, and W. V. Kern. 2005. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection. 33:397-400.
|
|
|
 |
 |
Home |
Image Bank |
Lecture Bank |
Knowledgebase |
Site Map |
Contact Us |
The Fungi |
Mycoses |
Drugs |
Laboratory |
Education & Tools |
About Us
|
|
|
|